Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

PRQR

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PRQR
일자시간출처헤드라인심볼기업
2024/02/1521:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2024/02/1420:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
2024/02/0920:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
2024/01/1921:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2024/01/0521:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2023/11/0800:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2023/09/2720:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2023/09/1506:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
2023/08/0320:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2023/08/0120:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
2023/05/1620:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
2023/04/2519:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
2023/04/2505:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
2023/03/3005:55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
2023/03/3005:54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
2023/03/3005:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
2023/03/1106:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
2023/02/1500:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2023/02/1007:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2023/02/1002:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2023/02/1001:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2023/02/0820:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2022/12/2406:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
2022/12/2321:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
2022/11/1020:35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
2022/11/1005:40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
2022/11/0921:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
2022/09/2205:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
2022/08/1210:15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
2022/08/1121:37TipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
 검색 관련기사 보기:NASDAQ:PRQR